Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Catalent to produce J&J’s COVID-19 vaccine in Indiana

By Chris Newmarker | March 24, 2021

CatalentCatalent will produce millions of extra doses of Johnson & Johnson’s COVID-19 vaccine at its recently expanded Bloomington, Ind. facility, according to a statement posted on LinkedIn.

Bloomberg broke the news yesterday, reporting that FDA has authorized the use of the facility to make the J&J vaccine.

Catalent announced late last year that it would spend $50 million to install an additional high-speed vial filling line in Bloomington. The company last year also agreed to make Moderna’s COVID-19 vaccine.

The COVID-19 vaccine manufacturing partnership between Catalent and J&J is but the latest in a string of partnerships meant to boost vaccine development and enable the U.S. to reach President Joe Biden’s goal of some post-pandemic normalcy by July Fourth. Other recent announcements include:

  • Baxter’s plans to make 60–90 million doses of the Moderna vaccine in 2021, also in Bloomington;
  • Merck providing two U.S. facilities to produce COVID-19 vaccine for its rival J&J.

 

 

 

Comments

  1. Elaine Frantz says

    March 30, 2021 at 12:20 pm

    Good morning,

    Excited to see that you are working on producing more of the vaccine. I am 65 and have been looking for the J&J in my area 44077 for sometime.

    Thank you,

    Elaine Frantz

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

Wuxi AppTec
WuXi STA constructing manufacturing facility in Middletown, Delaware
analyzing medical sample
Expert answers to nitrosamine impurity questions
Touchlight
Touchlight inks patent license deal with Pfizer related to the use of dbDNA in mRNA products
Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards